Trial intelligence / Profile preview

Alendronate Sodium for Osteopenia in Gaucher's Disease

NCT00004488Phase 2Completed

Sponsor
Cincinnati Children's Hospital Medical Center
Start
Oct 1998
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of alendronate in osteopenia, sponsored by Cincinnati Children's Hospital Medical Center. Started Oct 1998; status: completed.

02

Drugs

alendronate
03

Conditions

osteopenia

Beyond the preview

Go deeper on NCT00004488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call